Viewing Study NCT04995003

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:39 PM
Ignite Modification Date: 2026-05-17 @ 10:38 PM
Study NCT ID: NCT04995003
Status: RECRUITING
Last Update Posted: 2025-11-17
First Post: 2021-08-02
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
Sponsor: Baylor College of Medicine
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sarcoma View
None HER-2 Protein Overexpression View
None Osteosarcoma View
None Rhabdomyosarcoma View
None Ewing Sarcoma View
None Synovial Sarcoma View
None Soft Tissue Sarcoma View
None Undifferentiated Sarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Sarcoma View
None Her-2 Positive Sarcoma View
None autologous T cells View
None HER2 positive recurrent or progressive sarcoma View
None HER2 CAR T cells View
None Osteosarcoma View
None Rhabdomyosarcoma View
None Ewing sarcoma View
None Synovial sarcoma View
None Soft tissue sarcoma View
None Undifferentiated sarcoma View